title: [Maternal nutrition during pregnancy conditions the fetal pancreas development, hormonal status and diabetes mellitus and metabolic syndrome biomarkers at birth].
abstract: Pregnancy is a vital period where several hyperplasic, hypertrophic processes together with metabolic adaptation and preparation for extra-uterine life take place. Present review accounts for central aspects of nutrition throughout gestation on the embryonic and fetal periods. It is centered in the major changes occurring in fetal pancreas, with special mention to the susceptibility of this main glucose homeostasis organ to support nutritional changes during maturation and development. Studies performed in animal models as human are commented considering the role of maternal nutrition on β-cell mass size, insulin and other pancreatic hormones production, and insulin sensitivity. Details of both the thrifty genotype and phenotype hypothesis are given, indicating that hypo/subnutrition causes metabolic adaptations that permit the future body to grow and develop itself in limited environmental and energetic conditions. The Barker hypothesis is considered suggesting that this metabolic hypothesis is a double-edged sword in the actual abundance World. Lastly the review, taking into account our own research and other papers, analyses less known aspects that relate maternal diet with insulin resistance/sensitivity markers at delivery. Particularly the role of the saturated fatty acid/carbohydrate and omega-6/omega-3 ratios in the frame of maternal diet is reviewed considering the quality of those diets under the Healthy Eating Index and the Adherence to Mediterranean Diet scores and the relationship with insulin resistance profile at birth. Present review ends indicating that nutritional habits should be strongly stated before gestation in order to assure a proper nutrition since the first moment of pregnancy. This will support an adequate fetal and pancreatic growth and development, and in turn, adequate glucose homeostasis during pregnancy and later in life, slowing down or preventing from degenerative diseases related with metabolic syndrome and type 2 diabetes mellitus.
authors.affiliation: Departamento de Nutrición y Bromatología I (Nutrición), Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, España.
authors.forename: F J
authors.initials: FJ
authors.lastname: Sánchez-Muniz
authors.forename: E
authors.initials: E
authors.lastname: Gesteiro
authors.forename: M
authors.initials: M
authors.lastname: Espárrago Rodilla
authors.forename: B
authors.initials: B
authors.lastname: Rodríguez Bernal
authors.forename: S
authors.initials: S
authors.lastname: Bastida
mesh_terms: D000328:Adult; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000378:metabolism*; D004435:Eating; D005260:Female; D005333:Fetus / Q000502:physiology*; D006728:Hormones / Q000097:blood*; D006801:Humans; D044342:Malnutrition / Q000150:complications; D039382:Maternal Nutritional Physiological Phenomena; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000378:metabolism*; D010179:Pancreas / Q000254:growth & development*; D011247:Pregnancy
chemical_list: D006728:Hormones